ASCO: Doctors Rarely Discuss Costs of Cancer Care With Patients

This article originally appeared here.
Share this content:
ASCO: Cancer Patients Want to Talk About Costs With Docs
ASCO: Cancer Patients Want to Talk About Costs With Docs

(HealthDay News) -- Although financial distress is common, even in insured patients, discussion of costs of cancer care with doctors rarely happens, according to research to be presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.

S. Yousuf Zafar, M.D., M.H.S., of Duke University in Durham, N.C., and colleagues performed a cross-sectional study of insured adults with solid tumors who had been receiving anticancer therapy for one month or longer. In-person interviews of consecutive patients were conducted at a referral center and three rural oncology clinics.

The researchers interviewed 302 participants (85% response rate) with a median age of 60 years and median income of $60,000 per year; most (78%) had incurable cancer. Even though the majority surveyed (58%) had private health insurance, the mean score for the group reflected moderate financial distress. The majority (52%) expressed any desire to talk about costs with their doctor, but only 19% said they had such discussions.

Among 51 patients (17%) reporting high or overwhelming financial distress, only 13 (25%) had discussed financial concerns with the doctor. Overall, many (51%) claimed they wanted their doctors to consider costs in treatment decisions. Among those who discussed finances with their doctors, 57% thought that the discussion helped lower costs of care.

"With today's evolving health insurance landscape, cancer treatment-related costs to patients are more important than ever," Zafar said in a statement. "As providers, our team is convinced that cost discussions with our patients [are] important, and knowing that patients want to have these discussions should give us confidence in making this a routine practice."

More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs